Table 3 Results of Cox regression analyses for clinicopathological factors and CXCL16 in stromal cells (model 1) and co-expression of CXCL16 in cancer and stromal cells (model 2*)

<0.001^†

1.00

1.60

(0.97–2.64)

0.065

3.80

(2.13–6.77)

<0.001

<0.001^†

1.00

2.01

(1.30–3.11)

0.002

3.08

(1.74–5.44)

<0.001

0.009^†

1.00

1.17

(1.12–3.85)

0.020

2.08

(0.63–2.20)

0.618

0.040^†

1.00

1.52

(1.02–2.26)

0.040

2.15

(0.94–4.91)

0.069

1.00

1.70

(1.01–2.87)

0.046

<0.001^†

1.00

2.23

(1.48–3.35)

<0.001

0.80

(0.39–1.66)

0.555

1

0.55

(0.35–0.87)

0.011

0.031^†

1.00

0.57

(0.35–0.93)

0.023

0.42

(0.20–0.88)

0.022